658 related articles for article (PubMed ID: 27981376)
1. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?
Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ
Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic effects of Cholecalciferol supplementation in kidney stone formers with vitamin D deficiency].
Vitale C; Tricerri A; Bermond F; Fabbrini L; Guiotto C; Marangella M
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234237
[TBL] [Abstract][Full Text] [Related]
3. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D, Hypercalciuria and Kidney Stones.
Letavernier E; Daudon M
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562593
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of cholecalciferol supplementation in patients with calcium nephrolithiasis and vitamin D deficiency.
Vitale C; Marangella M; Bermond F; Fabbrini L; Tricerri A
World J Urol; 2021 Feb; 39(2):597-603. PubMed ID: 32367158
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D status in patients with recurrent kidney stones.
Pipili C; Oreopoulos DG
Nephron Clin Pract; 2012; 122(3-4):134-8. PubMed ID: 23712072
[TBL] [Abstract][Full Text] [Related]
7. Normocalcemic hyperparathyroidism in patients with recurrent kidney stones: a disease entity or vitamin D deficiency?
Pipili C; Sekecioglu N; Oreopoulos DG
Clin Nephrol; 2012 May; 77(5):352-7. PubMed ID: 22551880
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Supplementation and Risk of Hypercalciuria in Stone Formers.
Ganji MR; Shafii Z; Hakemi MS
Iran J Kidney Dis; 2019 Jan; 13(1):27-31. PubMed ID: 30851716
[TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
10. Impact of three different daily doses of vitamin D3 supplementation in healthy schoolchildren and adolescents from North India: a single-blind prospective randomised clinical trial.
Marwaha RK; Garg MK; Sethuraman G; Gupta N; Mithal A; Dang N; Kalaivani M; Ashraf Ganie M; Narang A; Arora P; Singh A; Chadha A; Manchanda RK
Br J Nutr; 2019 Mar; 121(5):538-548. PubMed ID: 30843501
[TBL] [Abstract][Full Text] [Related]
11. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.
Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC
Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535
[TBL] [Abstract][Full Text] [Related]
12. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
[TBL] [Abstract][Full Text] [Related]
13. Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.
Williams CP; Child DF; Hudson PR; Davies GK; Davies MG; John R; Anandaram PS; De Bolla AR
J Clin Pathol; 2001 Jan; 54(1):54-62. PubMed ID: 11271790
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and fetal-neonatal calcium homeostasis: findings from a randomized controlled trial of high-dose antenatal vitamin D supplementation.
Harrington J; Perumal N; Al Mahmud A; Baqui A; Roth DE
Pediatr Res; 2014 Sep; 76(3):302-9. PubMed ID: 24937546
[TBL] [Abstract][Full Text] [Related]
15. Male hypercalciuric stone formers with low renal calcium reabsorption.
Walker V; Cook P; Griffin DG
J Clin Pathol; 2014 Apr; 67(4):355-60. PubMed ID: 24218027
[TBL] [Abstract][Full Text] [Related]
16. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data.
Diamond TH; Ho KW; Rohl PG; Meerkin M
Med J Aust; 2005 Jul; 183(1):10-2. PubMed ID: 15992330
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Repletion in Kidney Stone Formers: A Randomized Controlled Trial.
Ferroni MC; Rycyna KJ; Averch TD; Semins MJ
J Urol; 2017 Apr; 197(4):1079-1083. PubMed ID: 27765695
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin D supplementation on 24-hour urine calcium in patients with calcium Urolithiasis and vitamin D deficiency.
Taheri M; Tavasoli S; Shokrzadeh F; Amiri FB; Basiri A
Int Braz J Urol; 2019; 45(2):340-346. PubMed ID: 30735332
[TBL] [Abstract][Full Text] [Related]
19. Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1,25-dihydroxyvitamin D
Melo TL; Esper PLG; Zambrano LI; Ormanji MS; Rodrigues FG; Heilberg IP
Urolithiasis; 2020 Feb; 48(1):19-26. PubMed ID: 31696245
[TBL] [Abstract][Full Text] [Related]
20. Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial.
Sardari Masihi L; Borumandnia N; Taheri M; Basiri A; Imani H; Jalali S; Tavasoli S
Eur J Med Res; 2023 Jul; 28(1):246. PubMed ID: 37481570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
